PEB Share Price |
||||
| Open | 0.49 | Change | Price | % |
| High | 0.49 | 1 Day | 0.00 | 0.00 |
| Low | 0.49 | 1 Week | 0.01 | 2.08 |
| Close | 0.49 | 1 Month | -0.08 | -14.04 |
| Volume | 107488 | 1 Year | -0.06 | -10.91 |
| 52 Week High 0.60 | ||||
| 52 Week Low 0.43 | ||||
| PEB Important Levels | |
| Resistance 2 | 0.49 |
| Resistance 1 | 0.49 |
| Pivot | 0.49 |
| Support 1 | 0.49 |
| Support 2 | 0.49 |
| NZE NewZealand Most Active Stocks | |||
| NPX | 5.45 | 0.55% | |
| NPX | 5.45 | 0.55% | |
| NPX | 5.45 | 0.55% | |
| TEL | 2.87 | 0.00% | |
| TEL | 2.87 | 0.00% | |
| TEL | 2.87 | 0.00% | |
| TEL | 2.87 | 0.00% | |
| DIL | 7.03 | 0.00% | |
| DIL | 7.03 | 0.00% | |
| ATM | 4.05 | 0.00% | |
| NZE NewZealand Top Gainers Stocks | |||
| ALF | 0.08 | 14.29% | |
| SDL | 2.30 | 4.55% | |
| SDL | 2.30 | 4.55% | |
| SDL | 2.30 | 4.55% | |
| SCY | 0.70 | 2.94% | |
| XRO | 26.02 | 2.85% | |
| BFW | 1.55 | 2.65% | |
| CDI | 0.80 | 2.56% | |
| CDI | 0.80 | 2.56% | |
| CDI | 0.80 | 2.56% | |
| NZE NewZealand Top Losers Stocks | |||
| CAV | 0.34 | -2.86% | |
| CAV | 0.34 | -2.86% | |
| TEN | 0.39 | -2.50% | |
| TEN | 0.39 | -2.50% | |
| TEN | 0.39 | -2.50% | |
| TEN | 0.39 | -2.50% | |
| TEN | 0.39 | -2.50% | |
| TEN | 0.39 | -2.50% | |
| OIC | 0.98 | -2.00% | |
| SKC | 4.27 | -1.84% | |
Pacific Edge Ltd (NZE: PEB)
| PEB Technical Analysis | 4 |
| As on 22nd Jun 2017 PEB Share Price closed @ 0.49 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.53 & Strong Sell for SHORT-TERM with Stoploss of 0.54 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| PEB Target for June | |
| 1st Target up-side | 0.55 |
| 2nd Target up-side | 0.59 |
| 3rd Target up-side | 0.63 |
| 1st Target down-side | 0.43 |
| 2nd Target down-side | 0.39 |
| 3rd Target down-side | 0.35 |
Pacific Edge Ltd ( NZE NewZealand Symbol : PEB ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
SAN
6.89 0.00 (0.00 %) LT : Buy ST : Sell |
AMP
5.30 0.03 (0.57 %) LT : Sell ST : Sell |
BLT
0.03 0.00 (0.00 %) LT : Strong Sell ST : Strong Sell |
BLT
0.03 0.00 (0.00 %) LT : Strong Sell ST : Strong Sell |
PHB
1.23 0.00 (0.00 %) LT : Sell ST : Sell |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart Pacific Edge Ltd ( PEB NZE NewZealand )
Your Comments and Response on Pacific Edge Ltd
PEB Business Profile
Pacific Edge Limited, a biomedical company, engages in the discovery, development, and commercialization of diagnostic and prognostic tools for the early detection and management of cancer. It offers Cxbladder, a non-invasive urine based test for the detection of bladder cancer; and Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The companys products in development and clinical trial stage include gastric cancer diagnosis and prognosis, gastric cancer triage, and melanoma diagnosis and prognosis. It also manages and operates laboratories for the detection of bladder cancer. The company was formerly known as Pacific Edge Biotechnology Limited and changed its name to Pacific Edge Limited in April 2010. Pacific Edge Limited was founded in 2001 and is based in Dunedin, New Zealand.